{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:28:27Z","timestamp":1789133307859,"version":"build-2803163510"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,19]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Hepatic veno-occlusive disease (VOD) is a complication of haematopoietic stem cell transplantation. VOD is associated with the occurrence of thrombotic microangiopathy (TMA). In haematopoietic stem cell transplantation, VOD and TMA are endothelial syndromes resulting from endothelial cell activation and dysfunction. In rheumatic disease, while TMA is not rare, there are few reports of VOD. In idiopathic myositis, only one case with VOD and TMA complications has been reported, and there are no published cases in juvenile dermatomyositis (JDM). We report a case of JDM manifesting VOD and TMA complications during the treatment for myositis and macrophage activation syndrome (MAS). A 5-year-old boy diagnosed as anti-nuclear matrix protein 2 antibody\u2013positive JDM was complicated by MAS. He received pulsed methylprednisolone, prednisolone, and tacrolimus, but JDM and MAS progressed. He was then treated with intravenous cyclophosphamide and cyclosporine A, with improvement in myositis symptoms and MAS. After initiation of cyclophosphamide and cyclosporine A, he developed haemolysis, painful hepatomegaly, liver damage, and ascites. He was diagnosed with VOD and TMA. Cyclophosphamide and cyclosporine A were discontinued, with recovery from VOD and TMA. The patient remained well on treatment with methotrexate, without any relapse of JDM and MAS to date. The presence of vasculopathy and hypercytokinaemia because of JDM and MAS exacerbated endothelial cell damage. In the present case, we suggest that the main cause of VOD was medication with CY and CsA, which had been used to treat acute exacerbation of MAS and JDM.<\/jats:p>","DOI":"10.1093\/mrcr\/rxac086","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T14:04:37Z","timestamp":1669212277000},"page":"404-409","source":"Crossref","is-referenced-by-count":8,"title":["Hepatic veno-occlusive disease accompanied by thrombotic microangiopathy developed during treatment of juvenile dermatomyositis and macrophage activation syndrome: A case report"],"prefix":"10.1093","volume":"7","author":[{"given":"Mariko","family":"Mouri","sequence":"first","affiliation":[{"name":"Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan"},{"name":"Department of Pediatrics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kanamori","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kyorin University School of Medicine , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Hiratoko","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hikarigaoka Hospital , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Morio","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9452-112X","authenticated-orcid":false,"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry , Tokyo, Japan"},{"name":"Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5398-0773","authenticated-orcid":false,"given":"Naoko","family":"Okiyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-4866","authenticated-orcid":false,"given":"Masaaki","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan"},{"name":"Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University , Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"2023061920012001400_R1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"2023061920012001400_R2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"2023061920012001400_R3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2169\/internalmedicine.37.694","article-title":"Hepatic veno-occlusive disease in a case of polymyositis associated with thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome","volume":"37","author":"Ishida","year":"1998","journal-title":"Internal Medicine"},{"key":"2023061920012001400_R4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10067-012-1998-0","article-title":"Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases","volume":"31","author":"Lin","year":"2012","journal-title":"Clin Rheumatol"},{"key":"2023061920012001400_R5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000312628","article-title":"Macrophage activation syndrome in autoimmune disease","volume":"153","author":"Deane","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"2023061920012001400_R6","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/rheumatology\/ken342","article-title":"Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases","volume":"47","author":"Fukaya","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2023061920012001400_R7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12969-015-0048-2","article-title":"Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels","volume":"13","author":"Wakiguchi","year":"2015","journal-title":"Pediatric Rheumatol"},{"key":"2023061920012001400_R8","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.autrev.2014.05.009","article-title":"A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria","volume":"13","author":"Poddighe","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2023061920012001400_R9","first-page":"1014","article-title":"Macrophage activation syndrome due to methotrexate in a 12-year-old boy with dermatomyositis","volume":"31","author":"Sterba","year":"2004","journal-title":"J Rheumatol"},{"key":"2023061920012001400_R10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/03009742.2013.863968","article-title":"Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis","volume":"43","author":"Lilleby","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"2023061920012001400_R11","first-page":"47","article-title":"Plasmapheresis for macrophage activation syndrome and multiorgan failure as first presentation of juvenile dermatomyositis","volume":"77","author":"Bustos","year":"2012","journal-title":"An Pediatr (Barc)"},{"key":"2023061920012001400_R12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1651-2227.2000.tb00351.x","article-title":"Platelet-specific hemophagocytosis in a patient with juvenile dermatomyositis","volume":"89","author":"Kobayashi","year":"2000","journal-title":"Acta Paediatr"},{"key":"2023061920012001400_R13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","article-title":"Sarcoplasmic MxA expression: a valuable marker of dermatomyositis","volume":"88","author":"Uruha","year":"2017","journal-title":"Neurology"},{"key":"2023061920012001400_R14","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023061920012001400_R15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"2023061920012001400_R16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"2023061920012001400_R17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/bmt.2015.52","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives \u2013 a position statement from the European Society for Blood and Marrow Transplantation (EBMT)","volume":"50","author":"Mohty","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"2023061920012001400_R18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023061920012001400_R19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00000421-199006000-00009","article-title":"Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan\/cyclophosphamide preparative regimen","volume":"13","author":"Brodsky","year":"1990","journal-title":"Am J Clin Oncol"},{"key":"2023061920012001400_R20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5500\/wjt.v6.i2.403","article-title":"Higher plasma bilirubin predicts veno-occlusive disease in early childhood undergoing hematopoietic stem cell transplantation with cyclosporine","volume":"6","author":"Kim","year":"2016","journal-title":"World J Transplant"},{"key":"2023061920012001400_R21","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.bbmt.2013.07.001","article-title":"Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus\u2013sirolimus on endothelial cells: protective effect of defibrotide","volume":"19","author":"Carmona","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023061920012001400_R22","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00002281-200209000-00012","article-title":"Macrophage activation syndrome","volume":"14","author":"Ravelli","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"2023061920012001400_R23","first-page":"642","volume-title":"Textbook of Pediatric Rheumatology","author":"Grom","year":"2015","edition":"7th"},{"key":"2023061920012001400_R24","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.2169\/internalmedicine.7966-16","article-title":"Hemophagocytic syndrome complicated with dermatomyositis controlled successfully with infliximab and conventional therapies","volume":"56","author":"Komiya","year":"2017","journal-title":"Intern Med"},{"key":"2023061920012001400_R25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/s10165-012-0661-6","article-title":"Hemophagocytic lymphohistiocytosis complicated by central nervous system lesions in a patient with dermatomyositis: a case presentation and literature review","volume":"23","author":"Yamashita","year":"2013","journal-title":"Mod Rheumatol"},{"key":"2023061920012001400_R26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3109\/14397595.2013.843753","article-title":"A case of dermatomyositis with rhabdomyolysis, rescued by intravenous immunoglobulin","volume":"25","author":"Mizoguchi","year":"2015","journal-title":"Mod Rheumatol"},{"key":"2023061920012001400_R27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00296-020-04590-9","article-title":"Macrophage activation syndrome in adult dermatomyositis: a case\u2013based review","volume":"40","author":"Ref Kishida","year":"2020","journal-title":"Rheumatol Int"},{"key":"2023061920012001400_R28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00296-019-04442-1","article-title":"Macrophage activation syndrome in juvenile dermatomyositis: a systematic review","volume":"40","author":"Poddighe","year":"2020","journal-title":"Rheumatol Int"},{"key":"2023061920012001400_R29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborate","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2023061920012001400_R30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cei.13026","article-title":"Characteristic elevation of soluble TNF receptor II: I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis","volume":"191","author":"Shimizu","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"2023061920012001400_R31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/rheumatology\/keaa299","article-title":"Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children","volume":"60","author":"Mizuta","year":"2021","journal-title":"Rheumatology"},{"key":"2023061920012001400_R32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0002-9270(00)02425-4","article-title":"Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases","volume":"96","author":"de Kerguenec","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2023061920012001400_R33","article-title":"The pathologic findings of skin, lymph node, liver, and bone marrow in patients with adult-onset Still disease: a comprehensive analysis of 40 cases","volume":"94","author":"Kim","year":"2015","journal-title":"Medicine"},{"key":"2023061920012001400_R34","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxac086\/47997924\/rxac086.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/7\/2\/404\/50646434\/rxac086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/7\/2\/404\/50646434\/rxac086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T20:05:19Z","timestamp":1687205119000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/7\/2\/404\/6843311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,11,23]]},"published-print":{"date-parts":[[2023,6,19]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxac086","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2022,11,23]]}}}